Riley Bove1, Muhammed T Malik1, Camilo Diaz-Cruz1, Alicia Chua1, Taylor J Saraceno1, David Bargiela1, Emily Greeke1, Bonnie I Glanz1, Brian C Healy1, Tanuja Chitnis2. 1. From the Partners Multiple Sclerosis Center (R.B., M.T.M., C.D.-C., A.C., T.J.S., D.B., E.G., B.I.G., B.C.H., T.C.), Department of Neurology, Brigham and Women's Hospital, Brookline; Harvard Medical School (R.B., B.I.G., B.C.H., T.C.), Boston; Ann Romney Center for Neurologic Diseases (R.B., D.B., B.I.G., B.C.H., T.C.), Harvard Medical School, Boston; and Massachusetts General Hospital Biostatistics Center (B.C.H.), Boston, MA. 2. From the Partners Multiple Sclerosis Center (R.B., M.T.M., C.D.-C., A.C., T.J.S., D.B., E.G., B.I.G., B.C.H., T.C.), Department of Neurology, Brigham and Women's Hospital, Brookline; Harvard Medical School (R.B., B.I.G., B.C.H., T.C.), Boston; Ann Romney Center for Neurologic Diseases (R.B., D.B., B.I.G., B.C.H., T.C.), Harvard Medical School, Boston; and Massachusetts General Hospital Biostatistics Center (B.C.H.), Boston, MA. tchitnis@partners.org.
Abstract
OBJECTIVE: To determine whether the 2D:4D ratio (ratio of the second and fourth digit lengths), a proxy for lower prenatal androgen to estrogen ratio, differs in men with and without multiple sclerosis (MS) using a case-control study design. METHODS: We obtained 2 digital scans of the right hand for men with MS presenting to a scheduled clinic visit at a large MS referral center, and for men without autoimmune or endocrine diseases. All individuals were aged 18 to 65 years, right-handed, and reported no prior digit trauma. We calculated a mean 2D:4D ratio using digital calipers. In participants with MS, we assessed age at first MS symptoms, MS type, and the MS Severity Score; 51 had provided a testosterone level within 10 years of symptom onset. Our primary analysis was a cross-sectional comparison of the 2D:4D ratio between men with and without MS, using a 2-sample t test for independent samples assuming unequal variance. RESULTS: In total, we scanned 137 men with MS and 145 men without MS. A statistically significant association between 2D:4D ratio and MS status was observed in the univariate logistic regression model (p<0.05). These differences were not associated with age or race, which differed between the 2 groups. In participants with MS, the 2D:4D ratio was not correlated with MS type, age at first symptoms, or MS Severity Score (p>0.15 for each), and it was not correlated with adult testosterone levels (r=0.06, p=0.68, n=51). CONCLUSIONS: During the prenatal period, low androgens could represent a risk factor for MS.
OBJECTIVE: To determine whether the 2D:4D ratio (ratio of the second and fourth digit lengths), a proxy for lower prenatal androgen to estrogen ratio, differs in men with and without multiple sclerosis (MS) using a case-control study design. METHODS: We obtained 2 digital scans of the right hand for men with MS presenting to a scheduled clinic visit at a large MS referral center, and for men without autoimmune or endocrine diseases. All individuals were aged 18 to 65 years, right-handed, and reported no prior digit trauma. We calculated a mean 2D:4D ratio using digital calipers. In participants with MS, we assessed age at first MS symptoms, MS type, and the MS Severity Score; 51 had provided a testosterone level within 10 years of symptom onset. Our primary analysis was a cross-sectional comparison of the 2D:4D ratio between men with and without MS, using a 2-sample t test for independent samples assuming unequal variance. RESULTS: In total, we scanned 137 men with MS and 145 men without MS. A statistically significant association between 2D:4D ratio and MS status was observed in the univariate logistic regression model (p<0.05). These differences were not associated with age or race, which differed between the 2 groups. In participants with MS, the 2D:4D ratio was not correlated with MS type, age at first symptoms, or MS Severity Score (p>0.15 for each), and it was not correlated with adult testosterone levels (r=0.06, p=0.68, n=51). CONCLUSIONS: During the prenatal period, low androgens could represent a risk factor for MS.
Authors: R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston Journal: Neurology Date: 2005-04-12 Impact factor: 9.910
Authors: Hannah Gardener; Kassandra L Munger; Tanuja Chitnis; Karin B Michels; Donna Spiegelman; Alberto Ascherio Journal: Epidemiology Date: 2009-07 Impact factor: 4.822